Uterine Atony
📧 Sign up to get email alerts when something new happens for Uterine Atony.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Exploration and Determination of Genomic Markers Predictive of Uterine Atony
A completed clinical trial from Baylor Research Institute exploring genomic markers that may predict uterine atony.
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Cooling the Uterus in C-section After Dysfunctional Labor [NA]
Clinical trial NCT02910115 evaluating uterine cooling during cesarean section for dysfunctional labor; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Perioperative Outcomes of Postpartum Hemorrhage in Patients Undergoing Cesarean Delivery
A completed clinical trial led by Mahidol University evaluating perioperative outcomes in patients with postpartum hemorrhage undergoing ces…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: DAISY Uterine Drain Device Evaluation [NA]
Clinical trial evaluating the DAISY Uterine Drain Device completed, investigating use in cesarean section complications and postpartum hemor…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony [Phase 2]
A Phase 2 clinical trial is recruiting to evaluate whether prophylactic intravenous calcium gluconate at cesarean delivery reduces blood los…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial [Phase 4]
Phase 4 randomized trial evaluating second-line uterotonic therapies for postpartum hemorrhage due to uterine atony; results have been poste…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery [Phase 3]
A Phase 3 clinical trial evaluating calcium chloride to prevent blood loss during intrapartum cesarean delivery has completed with results p…
-
FDA approval · 2024-01-25FDA Approved: CARBOPROST TROMETHAMINE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approves ANI Pharmaceuticals' original application for a generic carboprost tromethamine product, used to induce abortion and to treat p…
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Calcium Chloride for Prevention of Uterine Atony During Cesarean [Phase 1, Phase 2]
Clinical trial updates on calcium chloride for preventing uterine atony during cesarean section (Phase 1/Phase 2; completed with results pos…
-
FDA approval · 2021-01-15FDA Approved: METHYLERGONOVINE MALEATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved an original application for methyl ergonovine maleate (methylergonovine maleate) by Rising Pharma Holdings, Inc., enabling its …
-
FDA approval · 2020-05-01FDA Approved: METHYLERGONOVINE MALEATE — Original Application (Volley Pharmaceuticals, LLC)
FDA approved a generic version of methylergonovine maleate (brand Methergine) from Volley Pharmaceuticals through an Original Application (A…
-
FDA approval · 2019-03-20FDA Approved: METHYLERGONOVINE MALEATE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic methylergonovine maleate (ANDA 211455) for prevention of postpartum hemorrhage due to uterine atony after delive…
-
CLINICAL_TRIALS withdrawal · 2019-02-21Clinical Trial Update: Oxytocin Dosing at Planned Cesarean Section and Anemia [Phase 4]
A Phase 4 trial evaluating oxytocin dosing during planned cesarean section was withdrawn, with relevance to anemia from blood loss and uteri…
-
FDA approval · 2018-09-10FDA Approved: METHYLERGONOVINE MALEATE — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's generic methyl ergonovine maleate (ANDA 211483) as a uterotonic to help control postpartum …
-
FDA approval · 2018-05-15FDA Approved: METHYLERGONOVINE MALEATE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s original application for methylergonovine maleate, a generic medication used to prevent postpar…
-
CLINICAL_TRIALS withdrawal · 2017-07-31Clinical Trial Update: An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery [Phase 4]
A Phase 4 trial evaluating an evidence-based protocol for oxytocin administration in vaginal delivery has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Oxytocin And Uterotonic Agent Use For Cesarean Delivery [Phase 4]
Phase 4 clinical trial update on using oxytocin and other uterotonic agents during cesarean delivery for patients with uterine atony or hypo…
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section [Phase 4]
A Phase 4 clinical trial completed comparing tranexamic acid with uterine cooling for control of hemorrhage during cesarean section, with po…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage [NA]
Completed clinical trial evaluating uterine cooling during cesarean delivery to reduce blood loss and postpartum hemorrhage.
-
FDA label_change · 2015-02-25FDA Approved: METHERGINE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved a supplemental application for METHERGINE (methylergonovine maleate) from Lupin Pharmaceuticals, typically used to prevent or t…
-
FDA approval · 2014-10-02FDA Approved: PITOCIN — Supplemental Application (Par Health USA, LLC)
The FDA granted a supplemental approval for PITOCIN (oxytocin) from Par Health USA, LLC.
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT [Phase 4]
A Phase 4 randomized, three-arm trial assessing different oxytocin regimens to prevent uterine atony and postpartum hemorrhage during vagina…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section [Phase 4]
A Phase 4 trial compared two doses of carbetocin for prevention of uterine atony during elective cesarean section. The study status is compl…
-
FDA approval · 2013-03-29FDA Approved: METHERGINE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved a supplemental application for METHERGINE (methylergonovine maleate) submitted by Lupin Pharmaceuticals, Inc. The approval upda…
-
FDA label_change · 2013-03-06FDA Approved: METHYLERGONOVINE MALEATE — Supplemental Application (American Regent, Inc.)
FDA approved a supplemental application for methylergonovine maleate (American Regent, Inc.), resulting in updated labeling for this generic…